Fatodu, Hugh <br/><br/>
Evolving regulatory landscape with erythropoiesis-stimulating agents and impact on managed care.  [electronic resource] 

 -  The American journal of managed care  Mar 2010 
 - S74-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1936-2692 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anemia--drug therapy<br/>Cardiovascular Diseases--chemically induced<br/>Drug and Narcotic Control<br/>Drug-Related Side Effects and Adverse Reactions<br/>Hematinics--adverse effects<br/>Humans<br/>Insurance, Health, Reimbursement<br/>Kidney Failure, Chronic--complications<br/>Managed Care Programs<br/>Neoplasms--complications<br/>Product Surveillance, Postmarketing<br/>Risk Assessment<br/>Stroke--chemically induced<br/>United States--epidemiology<br/>United States Food and Drug Administration